Gamunex-c 40 gram/400 ML vial 400ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9MG3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,054
Award facts
- Contract value 100% obligated
- $45,054.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $45,054, was awarded on January 21, 2026, to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 40 gram/400 mL vials. The award is non-competitive and represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999 through December 2031. This prime contract vehicle enables DLA to procure a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office.
GAMUNEX-C is an intravenous immunoglobulin (IVIG) treatment used to address various immunological conditions affecting military service members and beneficiaries within the Defense Health Agency system. The firm fixed-price delivery order reflects the standardized approach DLA employs for pharmaceutical procurement, ensuring cost certainty while leveraging AmerisourceBergen's established position as a critical pharmaceutical distributor within the federal medical supply chain. This award demonstrates continued reliance on the company's capabilities to deliver specialized medical commodities that support military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9MG3?
SPE2DR26F9MG3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F9MG3 worth?
The government has obligated $45,054 on SPE2DR26F9MG3.
Is contract SPE2DR26F9MG3 an order under another contract?
Yes. SPE2DR26F9MG3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MG3 competed?
The extent of competition for SPE2DR26F9MG3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award